Biblio Discovery — Demo Discovery Service

5 results for "Uwe Trefzer"

Showing 1–5 · 1.09 seconds · RSS

  1. Journal Article

    Remission of an Intracardiac Melanoma Metastasis after Tremelimumab Therapy

    Sebastian Spethmann; Uwe Trefzer; Fabian Knebel

    Case Reports in Dermatology, Vol. 6 No. 1 · 2014 · English · DOAJ Scopus

    Tremelimumab is a fully human monoclonal antibody specific for human cytotoxic T lymphocyte-associated antigen 4. Administration of tremelimumab to patients with locally advanced and metastatic melanoma has resulted in a subset of patients with durable objective tumour regressions. Our…

  2. Journal Article Full text

    Proteome serological determination of tumor-associated antigens in melanoma.

    Michael Forgber; Uwe Trefzer; Wolfram Sterry et al.

    PLoS ONE, Vol. 4 No. 4 · 2009 · English · DOAJ Scopus

    Proteome serology may complement expression library-based approaches as strategy utilizing the patients' immune responses for the identification pathogenesis factors and potential targets for therapy and markers for diagnosis. Melanoma is a relatively immunogenic tumor and antigens recognized by…

    Also available at: PLOS

  3. Journal Article Full text

    The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

    Caroline J. Voskens; Simone M. Goldinger; Carmen Loquai et al.

    PLoS ONE, Vol. 8 No. 1 · 2013 · English · PLOS Scopus

    Background: Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA-4) blocking antibody, has been approved for the treatment of metastatic melanoma and induces adverse events (AE) in up to 64% of patients. Treatment algorithms for the management of common ipilimumab-induced AEs have lead to a…

    Also available at: DOAJ